These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 10955109)
1. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy]. Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109 [TBL] [Abstract][Full Text] [Related]
2. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients]. Moleda P; Majkowska L; Safranow K; Adler G; Goracy I Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464 [TBL] [Abstract][Full Text] [Related]
3. [Association between ACE gene polymorphism and therapeutic responsiveness of ACEI in diabetic nephropathy]. Wang L; Pan CY; Hu W Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):372-4. PubMed ID: 10923445 [TBL] [Abstract][Full Text] [Related]
4. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. Movva S; Alluri RV; Komandur S; Vattam K; Eppa K; Mukkavali KK; Mubigonda S; Saharia S; Shastry JC; Hasan Q J Diabetes Complications; 2007; 21(4):237-41. PubMed ID: 17616353 [TBL] [Abstract][Full Text] [Related]
5. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. Arfa I; Abid A; Nouira S; Elloumi-Zghal H; Malouche D; Mannai I; Zorgati MM; Ben Alaya N; Rebai A; Zouari B; Ben Ammar S; Ben Rayana MC; Hmida S; Blousa-Chabchoub S; Abdelhak S J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):32-6. PubMed ID: 18404607 [TBL] [Abstract][Full Text] [Related]
6. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680 [TBL] [Abstract][Full Text] [Related]
7. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy]. Liao L; Lei MX; Chen HL Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):553-6. PubMed ID: 15804059 [TBL] [Abstract][Full Text] [Related]
8. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. Viswanathan V; Zhu Y; Bala K; Dunn S; Snehalatha C; Ramachandran A; Jayaraman M; Sharma K JOP; 2001 Mar; 2(2):83-7. PubMed ID: 11867868 [TBL] [Abstract][Full Text] [Related]
9. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients. Pfohl M; Frost D; Koch M; Clemens P; Patzies A; Schmülling RM; Beischer W; Häring HU Horm Metab Res; 1998 May; 30(5):276-80. PubMed ID: 9660089 [TBL] [Abstract][Full Text] [Related]
10. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy. Eroglu Z; Cetinkalp S; Erdogan M; Kosova B; Karadeniz M; Kutukculer A; Gunduz C; Tetik A; Topcuoglu N; Ozgen AG; Tuzun M J Diabetes Complications; 2008; 22(3):186-90. PubMed ID: 18413162 [TBL] [Abstract][Full Text] [Related]
11. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Degirmenci I; Kebapci N; Basaran A; Efe B; Gunes HV; Akalin A; Kurt H; Urhan M; Demirustu C Int J Clin Pract; 2005 Oct; 59(10):1137-42. PubMed ID: 16178979 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes. Schmidt S; Ritz E Nephrol Dial Transplant; 1997; 12 Suppl 2():37-41. PubMed ID: 9269698 [TBL] [Abstract][Full Text] [Related]
13. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy. Wong TY; Szeto CC; Chow KM; Chan JC; Li PK Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175 [TBL] [Abstract][Full Text] [Related]
14. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients. Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561 [TBL] [Abstract][Full Text] [Related]
15. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy. Gohda T; Makita Y; Shike T; Kobayashi M; Funabiki K; Haneda M; Kikkawa R; Watanabe T; Baba T; Yoshida H; Tomino Y Clin Nephrol; 2001 Dec; 56(6):475-80. PubMed ID: 11770799 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972 [TBL] [Abstract][Full Text] [Related]
17. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy. Björck S; Blohmé G; Sylvén C; Mulec H Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between serum angiotensin I-converting enzyme activity and diabetic nephropathy in patients with type II diabetes]. Liao L; Lei M; Han X; Chen H; Fan C Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):263-6. PubMed ID: 12016801 [TBL] [Abstract][Full Text] [Related]
19. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885 [TBL] [Abstract][Full Text] [Related]
20. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus]. Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]